News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Tumor Organoids Predict How Well Patients Respond to Cancer Drugs
Ruth Williams | Feb 22, 2018
Testing treatments on mini tumors may save time in identifying which therapies work best, a new study shows.
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
John D. Loike and Jennifer Miller | Feb 1, 2017
What can be done to lower development costs and drug prices?
Repurposing Existing Drugs for New Indications
Anna Azvolinsky | Jan 1, 2017
An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.
Will Organs-in-a-Dish Ever Replace Animal Models?
Tanya Lewis | Jul 19, 2016
Increasingly sophisticated tissue organoids can model many aspects of disease, but animal studies retain a fundamental role in research, scientists say.
Desperately Seeking Shut-Eye
Anna Azvolinsky | Mar 1, 2016
New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.
Personalized Devices Predict Cancer Drug Response
Anna Azvolinsky | Apr 22, 2015
Two teams have developed tumor-implantable drug delivery devices to study real-time responses to multiple therapies in cancer patients.
Unauthorized HIV Trial Leader Fined
Bob Grant | Feb 3, 2014
A Spanish researcher faces a penalty after conducting a study for which he never obtained proper approvals or insurance.
Ketamine Alternative Shows Promise
Abby Olena | Oct 17, 2013
Researchers show that lanicemine is an effective antidepressant without the adverse effects of the related hallucinogenic drug.
Spinning Clinical Trials
Dan Cossins | Jan 16, 2013
Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.
A Dime a Dozen
Megan Scudellari | Jan 1, 2013
Affordable diagnostic tests tackle the world’s most pressing health problems.